| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | FRAS1 SRPX2 FBLN2 MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC | 6.42e-11 | 188 | 92 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.13e-10 | 60 | 92 | 8 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.59e-10 | 61 | 92 | 8 | GO:0098531 | |
| GeneOntologyMolecularFunction | zinc ion binding | NR2C2 SEC24D THRA THRB POLR1A SRSF7 ADAMTS3 PRICKLE1 PRICKLE3 TK1 ESRRA ESRRB ESRRG ZCRB1 MIB1 PRICKLE2 ZFAND6 ZFHX2 RNF216 PPARA NR1H4 | 4.89e-10 | 891 | 92 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 FAM20C NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 SPOCK1 MATN2 MATN3 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 1.13e-09 | 749 | 92 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | transition metal ion binding | NR2C2 FAM20C SEC24D THRA THRB POLR1A SRSF7 ADAMTS3 PRICKLE1 PRICKLE3 TK1 ESRRA ESRRB ESRRG ZCRB1 MIB1 PRICKLE2 ZFAND6 ZFHX2 RNF216 PPARA MUC2 NR1H4 | 2.88e-09 | 1189 | 92 | 23 | GO:0046914 |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 4.96e-06 | 25 | 92 | 4 | GO:0003707 | |
| GeneOntologyMolecularFunction | Notch binding | 6.83e-06 | 27 | 92 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | estrogen response element binding | 1.52e-05 | 11 | 92 | 3 | GO:0034056 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF12 NR2C2 THRA THRB ESRRA ESRRB ESRRG CARF ZNF429 ZFHX2 PPARA ZFP69 PRDM15 NR1H4 ZNF239 ZNF292 ZNF646 ZNF557 | 6.77e-05 | 1412 | 92 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 SRPX2 FBLN2 MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC CSRP3 | 2.17e-04 | 891 | 92 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | microfibril binding | 3.11e-04 | 6 | 92 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF12 NR2C2 THRA THRB ESRRA ESRRB ESRRG CARF ZNF429 ZFHX2 PPARA ZFP69 PRDM15 NR1H4 ZNF239 ZNF646 ZNF557 | 3.25e-04 | 1459 | 92 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | thyroid hormone binding | 4.34e-04 | 7 | 92 | 2 | GO:0070324 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF12 NR2C2 THRA THRB ESRRA ESRRB ESRRG CARF ZNF429 ZFHX2 PPARA PRDM15 NR1H4 ZNF239 ZNF646 | 5.36e-04 | 1244 | 92 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF12 NR2C2 THRA THRB ESRRA ESRRB ESRRG CARF ZNF429 ZFHX2 PPARA PRDM15 NR1H4 ZNF239 ZNF646 | 6.69e-04 | 1271 | 92 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.11e-03 | 560 | 92 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.19e-03 | 566 | 92 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | steroid binding | 3.34e-03 | 133 | 92 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activator activity | 4.57e-03 | 22 | 92 | 2 | GO:0030297 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 4.66e-03 | 73 | 92 | 3 | GO:0050840 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 FAM20C ABLIM1 FRAS1 EREG NTNG2 THRA THRB MEGF8 PRICKLE1 IFT57 LAMA1 MIB1 MUC19 LRP2 LAMA2 LRP4 PPARA TECTA DLL1 | 8.86e-07 | 1269 | 94 | 20 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TECTA TTC3 ANKRD27 PDLIM5 | 1.39e-06 | 748 | 94 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | embryonic brain development | 8.80e-06 | 29 | 94 | 4 | GO:1990403 | |
| GeneOntologyBiologicalProcess | axonogenesis | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TTC3 | 1.00e-05 | 566 | 94 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TTC3 ANKRD27 PDLIM5 | 1.57e-05 | 802 | 94 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 SPOCK1 OTOGL MATN2 LAMA1 CNTNAP2 PRICKLE2 LRP2 LAMA2 LRP4 TECTA TTC3 ANKRD27 PDLIM5 | 1.73e-05 | 1285 | 94 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TTC3 ANKRD27 PDLIM5 | 1.98e-05 | 819 | 94 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TTC3 ANKRD27 PDLIM5 | 2.17e-05 | 826 | 94 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ABLIM1 NELL2 NTNG2 LIMD1 MEGF8 PRICKLE1 MATN2 ESRRB LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TECTA TTC3 ANKRD27 PDLIM5 | 2.50e-05 | 1194 | 94 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | ABLIM1 NELL2 NTNG2 THRB MEGF8 PRICKLE1 SPOCK1 OTOGL MATN2 LAMA1 CNTNAP2 PRICKLE2 LRP2 LAMA2 LRP4 TECTA TTC3 ANKRD27 PDLIM5 | 2.79e-05 | 1463 | 94 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | CCN4 EREG PRICKLE1 LAMA1 CNTNAP2 DNER LAMA2 PPARA DLL1 CSRP3 PDLIM5 | 2.98e-05 | 531 | 94 | 11 | GO:0042692 |
| GeneOntologyBiologicalProcess | axon development | ABLIM1 NELL2 NTNG2 MEGF8 PRICKLE1 MATN2 LAMA1 CNTNAP2 LRP2 LAMA2 LRP4 TTC3 | 3.47e-05 | 642 | 94 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 3.53e-05 | 199 | 94 | 7 | GO:0051147 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 4.96e-05 | 210 | 94 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | female courtship behavior | 6.15e-05 | 3 | 94 | 2 | GO:0008050 | |
| GeneOntologyBiologicalProcess | positive regulation of thyroid hormone receptor signaling pathway | 6.15e-05 | 3 | 94 | 2 | GO:0002157 | |
| GeneOntologyBiologicalProcess | odontogenesis | 6.68e-05 | 151 | 94 | 6 | GO:0042476 | |
| GeneOntologyBiologicalProcess | embryo development | JAG2 NR2C2 SEC24D FRAS1 MEGF8 ADAMTS3 PRICKLE1 IFT57 ESRRB LAMA1 MIB1 CNTNAP2 PRICKLE2 LRP2 LAMA2 LRP4 TECTA DLL1 | 7.51e-05 | 1437 | 94 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | synapse assembly | 8.26e-05 | 308 | 94 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 9.98e-05 | 53 | 94 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 1.30e-04 | 107 | 94 | 5 | GO:0042475 | |
| GeneOntologyBiologicalProcess | muscle structure development | CCN4 NR2C2 EREG PRICKLE1 LAMA1 CNTNAP2 DNER LRP2 LAMA2 PPARA DLL1 CSRP3 PDLIM5 | 1.36e-04 | 858 | 94 | 13 | GO:0061061 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 1.60e-04 | 177 | 94 | 6 | GO:0055007 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.83e-04 | 259 | 94 | 7 | GO:0055001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 2.40e-04 | 122 | 94 | 5 | GO:0055013 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 2.79e-04 | 368 | 94 | 8 | GO:0030111 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 3.05e-04 | 6 | 94 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 3.05e-04 | 6 | 94 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 3.11e-04 | 71 | 94 | 4 | GO:0099084 | |
| GeneOntologyBiologicalProcess | epithelium development | JAG2 FAM20C FRAS1 EREG THRA THRB EGF MEGF8 PRICKLE1 IFT57 LAMA1 MIB1 LRP2 LRP4 TECTA DLL1 MUC2 | 3.14e-04 | 1469 | 94 | 17 | GO:0060429 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 3.26e-04 | 202 | 94 | 6 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 3.26e-04 | 202 | 94 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | axon guidance | 3.28e-04 | 285 | 94 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 3.28e-04 | 285 | 94 | 7 | GO:0060828 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.35e-04 | 286 | 94 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 3.46e-04 | 132 | 94 | 5 | GO:0055006 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | JAG2 FRAS1 MEGF8 PRICKLE1 IFT57 ESRRB MIB1 LRP2 LRP4 TECTA DLL1 | 3.97e-04 | 713 | 94 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 4.18e-04 | 391 | 94 | 8 | GO:0051146 | |
| GeneOntologyBiologicalProcess | courtship behavior | 4.25e-04 | 7 | 94 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 4.68e-04 | 79 | 94 | 4 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 4.91e-04 | 80 | 94 | 4 | GO:0003143 | |
| GeneOntologyBiologicalProcess | aorta development | 4.91e-04 | 80 | 94 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | negative regulation of myoblast differentiation | 4.95e-04 | 34 | 94 | 3 | GO:0045662 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NR2C2 ABLIM1 THRA THRB ESRRA ESRRB ESRRG CARF PPARA CAMTA1 DLL1 PRDM15 CSRP3 NR1H4 ZNF292 ZNF646 | 5.12e-04 | 1390 | 94 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 5.18e-04 | 619 | 94 | 10 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 5.25e-04 | 221 | 94 | 6 | GO:0035051 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 5.32e-04 | 309 | 94 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 5.65e-04 | 83 | 94 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone receptor signaling pathway | 5.65e-04 | 8 | 94 | 2 | GO:0002155 | |
| GeneOntologyBiologicalProcess | ERBB2-EGFR signaling pathway | 5.65e-04 | 8 | 94 | 2 | GO:0038134 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 5.79e-04 | 516 | 94 | 9 | GO:0016055 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 6.28e-04 | 416 | 94 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | heart development | CCN4 MEGF8 PRICKLE1 IFT57 MIB1 LRP2 LTBP1 PPARA DLL1 CSRP3 PDLIM5 | 6.54e-04 | 757 | 94 | 11 | GO:0007507 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 6.79e-04 | 421 | 94 | 8 | GO:0060562 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 6.89e-04 | 38 | 94 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 6.89e-04 | 38 | 94 | 3 | GO:0140058 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 7.25e-04 | 9 | 94 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 7.25e-04 | 9 | 94 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 7.25e-04 | 9 | 94 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 7.43e-04 | 327 | 94 | 7 | GO:0048738 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 7.85e-04 | 158 | 94 | 5 | GO:0030177 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 8.01e-04 | 40 | 94 | 3 | GO:0099558 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 8.32e-04 | 92 | 94 | 4 | GO:0045661 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 8.66e-04 | 93 | 94 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 8.81e-04 | 244 | 94 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | type I pneumocyte differentiation | 9.03e-04 | 10 | 94 | 2 | GO:0060509 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 9.18e-04 | 667 | 94 | 10 | GO:0060627 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FAM20C EREG EGF MEGF8 ADAMTS3 PRICKLE1 LRP2 LRP4 LTBP1 LTBP2 PPARA DLL1 CSRP3 NR1H4 | 9.33e-04 | 1186 | 94 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 9.76e-04 | 96 | 94 | 4 | GO:0060113 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 9.91e-04 | 43 | 94 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 9.99e-04 | 344 | 94 | 7 | GO:0060070 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.01e-03 | 558 | 94 | 9 | GO:0060537 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.04e-03 | 561 | 94 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 1.06e-03 | 44 | 94 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.09e-03 | 349 | 94 | 7 | GO:0014706 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.09e-03 | 99 | 94 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.10e-03 | 11 | 94 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cell junction assembly | NTNG2 SRPX2 PRICKLE1 CNTNAP2 DNER PRICKLE2 LRP4 PDLIM5 NR1H4 | 1.15e-03 | 569 | 94 | 9 | GO:0034329 |
| GeneOntologyBiologicalProcess | epithelial tube formation | 1.18e-03 | 173 | 94 | 5 | GO:0072175 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.21e-03 | 46 | 94 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 1.27e-03 | 103 | 94 | 4 | GO:0035050 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.31e-03 | 104 | 94 | 4 | GO:0042490 | |
| GeneOntologyBiologicalProcess | female mating behavior | 1.32e-03 | 12 | 94 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | regulation of bile acid biosynthetic process | 1.32e-03 | 12 | 94 | 2 | GO:0070857 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 1.41e-03 | 106 | 94 | 4 | GO:0051149 | |
| GeneOntologyBiologicalProcess | tube formation | 1.66e-03 | 187 | 94 | 5 | GO:0035148 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 1.78e-03 | 190 | 94 | 5 | GO:0016331 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.80e-03 | 14 | 94 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.84e-03 | 114 | 94 | 4 | GO:0008593 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.96e-03 | 387 | 94 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 2.02e-03 | 389 | 94 | 7 | GO:0030100 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiocyte differentiation | 2.08e-03 | 15 | 94 | 2 | GO:1905208 | |
| GeneOntologyBiologicalProcess | regulation of bile acid metabolic process | 2.08e-03 | 15 | 94 | 2 | GO:1904251 | |
| GeneOntologyBiologicalProcess | protein polyubiquitination | 2.09e-03 | 289 | 94 | 6 | GO:0000209 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | CCN4 EREG LIMD1 PRICKLE1 ESRRB MIB1 LRP4 PPARA DLL1 TTC3 CSRP3 | 2.09e-03 | 875 | 94 | 11 | GO:0045596 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.13e-03 | 198 | 94 | 5 | GO:0007605 | |
| GeneOntologyBiologicalProcess | cell growth involved in cardiac muscle cell development | 2.13e-03 | 56 | 94 | 3 | GO:0061049 | |
| GeneOntologyBiologicalProcess | physiological muscle hypertrophy | 2.13e-03 | 56 | 94 | 3 | GO:0003298 | |
| GeneOntologyBiologicalProcess | physiological cardiac muscle hypertrophy | 2.13e-03 | 56 | 94 | 3 | GO:0003301 | |
| GeneOntologyBiologicalProcess | circulatory system development | CCN4 EREG SRPX2 EGF MEGF8 PRICKLE1 IFT57 LAMA1 MIB1 LRP2 LTBP1 PPARA DLL1 CSRP3 PDLIM5 | 2.14e-03 | 1442 | 94 | 15 | GO:0072359 |
| GeneOntologyCellularComponent | extracellular matrix | CCN4 FRAS1 SRPX2 FBLN2 MEGF6 ADAMTS3 OTOGL MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC | 3.49e-08 | 656 | 94 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | CCN4 FRAS1 SRPX2 FBLN2 MEGF6 ADAMTS3 OTOGL MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC | 3.64e-08 | 658 | 94 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | FRAS1 SRPX2 FBLN2 MEGF6 ADAMTS3 MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 MUC2 | 4.50e-06 | 530 | 94 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | mucus layer | 5.98e-05 | 3 | 94 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | matrilin complex | 1.19e-04 | 4 | 94 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | asymmetric synapse | ABLIM1 PRICKLE1 SPOCK1 GPR158 MIB1 CNTNAP2 PRICKLE2 LRP4 PDLIM5 | 2.97e-04 | 477 | 94 | 9 | GO:0032279 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ABLIM1 PRICKLE1 SPOCK1 GPR158 MIB1 CNTNAP2 PRICKLE2 LRP4 PDLIM5 | 5.79e-04 | 523 | 94 | 9 | GO:0098984 |
| GeneOntologyCellularComponent | postsynapse | ABLIM1 SUSD4 PRICKLE1 SPOCK1 GPR158 MIB1 CNTNAP2 PRICKLE2 LAMA2 LRP4 RNF216 CADPS2 PDLIM5 | 6.21e-04 | 1018 | 94 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | 9.72e-04 | 451 | 94 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.39e-03 | 107 | 94 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.94e-03 | 503 | 94 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | basement membrane | 2.25e-03 | 122 | 94 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.60e-03 | 17 | 94 | 2 | GO:0098637 | |
| Domain | EGF | TMEFF1 HYAL4 JAG2 FRAS1 NELL2 EREG NTNG2 FBLN2 OIT3 MALRD1 EGF MEGF6 MEGF8 MATN2 MATN3 LAMA1 CNTNAP2 DNER NOTCH2NLA LRP2 LAMA2 LRP4 LTBP1 LTBP2 TECTA DLL1 NOTCH2NLC | 1.02e-29 | 235 | 93 | 27 | SM00181 |
| Domain | EGF-like_dom | TMEFF1 JAG2 FRAS1 NELL2 EREG NTNG2 FBLN2 OIT3 MALRD1 EGF MEGF6 MEGF8 MATN2 MATN3 LAMA1 CNTNAP2 DNER NOTCH2NLA LRP2 LAMA2 LRP4 LTBP1 LTBP2 TECTA DLL1 NOTCH2NLC | 1.68e-27 | 249 | 93 | 26 | IPR000742 |
| Domain | EGF_2 | TMEFF1 HYAL4 JAG2 NELL2 EREG NTNG2 FBLN2 OIT3 MALRD1 EGF MEGF6 MEGF8 MATN2 MATN3 LAMA1 CNTNAP2 DNER NOTCH2NLA LRP2 LAMA2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 2.56e-25 | 265 | 93 | 25 | PS01186 |
| Domain | EGF_1 | TMEFF1 HYAL4 JAG2 NELL2 EREG NTNG2 FBLN2 OIT3 MALRD1 EGF MEGF6 MEGF8 LAMA1 CNTNAP2 DNER NOTCH2NLA LRP2 LAMA2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 7.58e-23 | 255 | 93 | 23 | PS00022 |
| Domain | EGF-like_CS | TMEFF1 JAG2 NELL2 EREG NTNG2 FBLN2 MALRD1 EGF MEGF6 MEGF8 MATN2 MATN3 LAMA1 CNTNAP2 DNER NOTCH2NLA LRP2 LAMA2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 1.30e-22 | 261 | 93 | 23 | IPR013032 |
| Domain | EGF_3 | TMEFF1 JAG2 NELL2 EREG NTNG2 FBLN2 OIT3 MALRD1 EGF MEGF6 MEGF8 MATN2 MATN3 CNTNAP2 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 3.19e-22 | 235 | 93 | 22 | PS50026 |
| Domain | EGF | JAG2 EREG NTNG2 MALRD1 EGF MEGF6 MATN2 MATN3 CNTNAP2 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 TECTA DLL1 NOTCH2NLC | 1.14e-21 | 126 | 93 | 18 | PF00008 |
| Domain | EGF_CA | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 MATN2 MATN3 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 2.58e-20 | 122 | 93 | 17 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 MATN2 MATN3 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 3.45e-20 | 124 | 93 | 17 | IPR001881 |
| Domain | ASX_HYDROXYL | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 MATN2 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 3.55e-20 | 100 | 93 | 16 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 MATN2 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 9.50e-20 | 106 | 93 | 16 | IPR000152 |
| Domain | EGF_Ca-bd_CS | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 9.81e-19 | 97 | 93 | 15 | IPR018097 |
| Domain | EGF_CA | JAG2 NELL2 FBLN2 OIT3 EGF MEGF6 MEGF8 DNER NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 DLL1 NOTCH2NLC | 1.35e-18 | 99 | 93 | 15 | PS01187 |
| Domain | Growth_fac_rcpt_ | JAG2 CCN4 FRAS1 NELL2 FBLN2 EGF MEGF6 MEGF8 MATN2 MATN3 LAMA1 DNER LRP2 LRP4 LTBP1 LTBP2 DLL1 | 1.93e-18 | 156 | 93 | 17 | IPR009030 |
| Domain | EGF_CA | JAG2 NELL2 FBLN2 EGF MEGF6 MEGF8 MATN2 MATN3 NOTCH2NLA LRP2 LRP4 LTBP1 LTBP2 NOTCH2NLC | 7.05e-18 | 86 | 93 | 14 | PF07645 |
| Domain | VWC_out | 2.89e-12 | 19 | 93 | 7 | SM00215 | |
| Domain | VWC | 1.20e-11 | 38 | 93 | 8 | SM00214 | |
| Domain | VWFC_2 | 1.20e-11 | 38 | 93 | 8 | PS50184 | |
| Domain | VWF_dom | 2.86e-11 | 42 | 93 | 8 | IPR001007 | |
| Domain | zf-C4 | 6.21e-11 | 46 | 93 | 8 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 6.21e-11 | 46 | 93 | 8 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 6.21e-11 | 46 | 93 | 8 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 6.21e-11 | 46 | 93 | 8 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 6.21e-11 | 46 | 93 | 8 | PS00031 | |
| Domain | ZnF_C4 | 6.21e-11 | 46 | 93 | 8 | SM00399 | |
| Domain | - | 7.46e-11 | 47 | 93 | 8 | 1.10.565.10 | |
| Domain | HOLI | 8.91e-11 | 48 | 93 | 8 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 8.91e-11 | 48 | 93 | 8 | IPR000536 | |
| Domain | Hormone_recep | 8.91e-11 | 48 | 93 | 8 | PF00104 | |
| Domain | - | 3.76e-10 | 57 | 93 | 8 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.35e-10 | 58 | 93 | 8 | IPR013088 | |
| Domain | TIL_dom | 5.31e-09 | 14 | 93 | 5 | IPR002919 | |
| Domain | EGF_extracell | 1.88e-08 | 60 | 93 | 7 | IPR013111 | |
| Domain | EGF_2 | 1.88e-08 | 60 | 93 | 7 | PF07974 | |
| Domain | VWFC_1 | 2.24e-08 | 36 | 93 | 6 | PS01208 | |
| Domain | LIM | 5.06e-08 | 69 | 93 | 7 | PF00412 | |
| Domain | - | 5.61e-08 | 70 | 93 | 7 | 2.10.110.10 | |
| Domain | Znf_LIM | 6.19e-08 | 71 | 93 | 7 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 6.19e-08 | 71 | 93 | 7 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 6.19e-08 | 71 | 93 | 7 | PS50023 | |
| Domain | LIM | 6.19e-08 | 71 | 93 | 7 | SM00132 | |
| Domain | Oest-rel_rcp | 1.20e-07 | 3 | 93 | 3 | IPR027289 | |
| Domain | LIM3_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033727 | |
| Domain | LIM2_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033726 | |
| Domain | PET_prickle | 1.20e-07 | 3 | 93 | 3 | IPR033723 | |
| Domain | cEGF | 1.66e-07 | 26 | 93 | 5 | IPR026823 | |
| Domain | cEGF | 1.66e-07 | 26 | 93 | 5 | PF12662 | |
| Domain | TIL | 2.77e-07 | 12 | 93 | 4 | PF01826 | |
| Domain | C8 | 2.77e-07 | 12 | 93 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 3.98e-07 | 13 | 93 | 4 | IPR014853 | |
| Domain | C8 | 3.98e-07 | 13 | 93 | 4 | SM00832 | |
| Domain | Laminin_EGF | 7.92e-07 | 35 | 93 | 5 | PF00053 | |
| Domain | EGF_Lam | 7.92e-07 | 35 | 93 | 5 | SM00180 | |
| Domain | VWD | 1.00e-06 | 16 | 93 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.00e-06 | 16 | 93 | 4 | IPR001846 | |
| Domain | VWFD | 1.00e-06 | 16 | 93 | 4 | PS51233 | |
| Domain | VWD | 1.00e-06 | 16 | 93 | 4 | PF00094 | |
| Domain | ThyrH_rcpt | 1.19e-06 | 5 | 93 | 3 | IPR001728 | |
| Domain | Oest_rcpt/oest-rel_rcp | 1.19e-06 | 5 | 93 | 3 | IPR024178 | |
| Domain | Laminin_EGF | 1.21e-06 | 38 | 93 | 5 | IPR002049 | |
| Domain | CTCK_1 | 1.67e-06 | 18 | 93 | 4 | PS01185 | |
| Domain | PET | 2.36e-06 | 6 | 93 | 3 | PF06297 | |
| Domain | PET_domain | 2.36e-06 | 6 | 93 | 3 | IPR010442 | |
| Domain | PET | 2.36e-06 | 6 | 93 | 3 | PS51303 | |
| Domain | CT | 3.93e-06 | 22 | 93 | 4 | SM00041 | |
| Domain | Cys_knot_C | 6.73e-06 | 25 | 93 | 4 | IPR006207 | |
| Domain | CTCK_2 | 6.73e-06 | 25 | 93 | 4 | PS01225 | |
| Domain | hEGF | 1.08e-05 | 28 | 93 | 4 | PF12661 | |
| Domain | VWC | 1.08e-05 | 28 | 93 | 4 | PF00093 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.40e-05 | 10 | 93 | 3 | IPR000003 | |
| Domain | EGF_LAM_2 | 1.43e-05 | 30 | 93 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.43e-05 | 30 | 93 | 4 | PS01248 | |
| Domain | MKRN1_C | 2.45e-05 | 2 | 93 | 2 | PF15815 | |
| Domain | LIM1_prickle | 2.45e-05 | 2 | 93 | 2 | IPR033725 | |
| Domain | MKRN1_C | 2.45e-05 | 2 | 93 | 2 | IPR031644 | |
| Domain | Ldl_recept_b | 4.18e-05 | 14 | 93 | 3 | PF00058 | |
| Domain | LDLRB | 4.18e-05 | 14 | 93 | 3 | PS51120 | |
| Domain | Laminin_G_2 | 4.59e-05 | 40 | 93 | 4 | PF02210 | |
| Domain | LY | 5.21e-05 | 15 | 93 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.21e-05 | 15 | 93 | 3 | IPR000033 | |
| Domain | Laminin_N | 6.39e-05 | 16 | 93 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 6.39e-05 | 16 | 93 | 3 | PS51117 | |
| Domain | Laminin_N | 6.39e-05 | 16 | 93 | 3 | PF00055 | |
| Domain | LamNT | 6.39e-05 | 16 | 93 | 3 | SM00136 | |
| Domain | LamG | 6.71e-05 | 44 | 93 | 4 | SM00282 | |
| Domain | ZnF_C3H1 | 9.48e-05 | 48 | 93 | 4 | SM00356 | |
| Domain | zf-CCCH | 1.03e-04 | 49 | 93 | 4 | PF00642 | |
| Domain | - | 1.46e-04 | 4 | 93 | 2 | 1.20.5.30 | |
| Domain | Matrilin_ccoil | 1.46e-04 | 4 | 93 | 2 | PF10393 | |
| Domain | DSL | 1.46e-04 | 4 | 93 | 2 | PF01414 | |
| Domain | Matrilin_coiled-coil_trimer | 1.46e-04 | 4 | 93 | 2 | IPR019466 | |
| Domain | Matrilin_ccoil | 1.46e-04 | 4 | 93 | 2 | SM01279 | |
| Domain | DSL | 1.46e-04 | 4 | 93 | 2 | SM00051 | |
| Domain | Laminin_G | 1.99e-04 | 58 | 93 | 4 | IPR001791 | |
| Domain | Znf_CCCH | 1.99e-04 | 58 | 93 | 4 | IPR000571 | |
| Domain | DSL | 2.43e-04 | 5 | 93 | 2 | IPR001774 | |
| Domain | Laminin_aI | 2.43e-04 | 5 | 93 | 2 | IPR009254 | |
| Domain | Laminin_I | 2.43e-04 | 5 | 93 | 2 | PF06008 | |
| Domain | Laminin_II | 2.43e-04 | 5 | 93 | 2 | PF06009 | |
| Domain | DSL | 2.43e-04 | 5 | 93 | 2 | PS51051 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.25e-10 | 48 | 74 | 8 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.87e-10 | 53 | 74 | 8 | M8276 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 4.11e-08 | 38 | 74 | 6 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 4.11e-08 | 38 | 74 | 6 | MM15865 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 8.14e-06 | 25 | 74 | 4 | M27879 | |
| Pathway | PID_RXR_VDR_PATHWAY | 9.58e-06 | 26 | 74 | 4 | M162 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.14e-05 | 9 | 74 | 3 | M47866 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.30e-05 | 28 | 74 | 4 | MM15042 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 1.73e-05 | 30 | 74 | 4 | M27323 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.98e-05 | 31 | 74 | 4 | M592 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.22e-05 | 11 | 74 | 3 | MM1432 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.22e-05 | 11 | 74 | 3 | M18837 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 6.04e-05 | 15 | 74 | 3 | M27202 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 8.96e-05 | 17 | 74 | 3 | MM14700 | |
| Pathway | REACTOME_GAB1_SIGNALOSOME | 8.96e-05 | 17 | 74 | 3 | M10450 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.24e-04 | 49 | 74 | 4 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.27e-04 | 19 | 74 | 3 | MM15594 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.71e-04 | 300 | 74 | 8 | M610 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.73e-04 | 21 | 74 | 3 | MM15706 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.99e-04 | 22 | 74 | 3 | M27210 | |
| Pathway | PID_NOTCH_PATHWAY | 2.56e-04 | 59 | 74 | 4 | M17 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.66e-04 | 109 | 74 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.73e-04 | 60 | 74 | 4 | MM15636 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.94e-04 | 25 | 74 | 3 | M39713 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.71e-04 | 27 | 74 | 3 | M39545 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.61e-04 | 7 | 74 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 5.61e-04 | 7 | 74 | 2 | M47805 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF12 NR2C2 THRA THRB ESRRA ESRRB ESRRG ZNF429 PPARA ZFP69 NR1H4 ZNF557 | 6.09e-04 | 768 | 74 | 12 | MM14851 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.10e-04 | 74 | 74 | 4 | M616 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.17e-04 | 32 | 74 | 3 | MM14854 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.75e-04 | 76 | 74 | 4 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 6.77e-04 | 33 | 74 | 3 | M604 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF12 NR2C2 THRA THRB POLR1A SRSF7 ESRRA ESRRB ESRRG ZNF429 PPARA ZFP69 NR1H4 ZNF557 | 7.64e-04 | 1022 | 74 | 14 | MM15436 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.49e-04 | 37 | 74 | 3 | M27134 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 9.56e-04 | 9 | 74 | 2 | M27133 | |
| Pathway | KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY | 9.56e-04 | 9 | 74 | 2 | M47629 | |
| Pathway | REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA | 9.56e-04 | 9 | 74 | 2 | MM14853 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.11e-03 | 39 | 74 | 3 | MM14604 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.11e-03 | 39 | 74 | 3 | MM14601 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.45e-03 | 11 | 74 | 2 | M158 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.45e-03 | 11 | 74 | 2 | MM15478 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.58e-03 | 44 | 74 | 3 | M26969 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 1.73e-03 | 12 | 74 | 2 | MM14777 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.79e-03 | 46 | 74 | 3 | M239 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | GCNT7 FAM20C SEC24D THRA THRB MEGF6 ADAMTS3 MATN3 MUC19 LTBP1 PPARA TECTA MUC2 MUC5AC NR1H4 ALG13 | 1.96e-03 | 1389 | 74 | 16 | MM15307 |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.04e-03 | 13 | 74 | 2 | M27729 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 2.04e-03 | 13 | 74 | 2 | MM14701 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.04e-03 | 13 | 74 | 2 | M47423 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.04e-03 | 13 | 74 | 2 | MM15320 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.15e-03 | 49 | 74 | 3 | MM14695 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.32e-03 | 258 | 74 | 6 | MM14572 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.37e-03 | 14 | 74 | 2 | MM1473 | |
| Pathway | WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM | 2.37e-03 | 14 | 74 | 2 | M48059 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 2.37e-03 | 14 | 74 | 2 | M719 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 2.37e-03 | 14 | 74 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.37e-03 | 14 | 74 | 2 | MM14531 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.69e-03 | 53 | 74 | 3 | M27039 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 2.73e-03 | 15 | 74 | 2 | M27608 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 2.73e-03 | 15 | 74 | 2 | M15181 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 3.11e-03 | 16 | 74 | 2 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.11e-03 | 16 | 74 | 2 | M570 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.11e-03 | 16 | 74 | 2 | M47424 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.48e-03 | 58 | 74 | 3 | M29616 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 3.51e-03 | 17 | 74 | 2 | M39389 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 3.63e-03 | 120 | 74 | 4 | MM14982 | |
| Pubmed | 9.01e-10 | 167 | 95 | 9 | 22159717 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.68e-09 | 248 | 95 | 10 | 24006456 | |
| Pubmed | MKRN4P ABLIM1 THRA LIMD1 PRICKLE3 ESRRB MKRN1 ESRRG ZNF429 PPARA DLL1 PDLIM5 ZNF239 ZNF292 ZNF646 | 5.37e-09 | 808 | 95 | 15 | 20412781 | |
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 20838448 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 29888756 | ||
| Pubmed | 1.97e-08 | 3 | 95 | 3 | 15598686 | ||
| Pubmed | 2.34e-08 | 64 | 95 | 6 | 22261194 | ||
| Pubmed | MKRN4P ABLIM1 THRA LIMD1 PRICKLE3 ESRRA ESRRB MKRN1 ESRRG ZFAND6 ZFHX2 PDLIM5 ZNF292 | 7.09e-08 | 709 | 95 | 13 | 22988430 | |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 22691042 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 18039682 | ||
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 29940916 | ||
| Pubmed | JAG2 NELL2 FBLN2 MEGF6 MEGF8 MATN2 NOTCH2NLA LRP2 LTBP1 PREPL PDLIM5 ALG13 | 1.07e-07 | 608 | 95 | 12 | 16713569 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 1.97e-07 | 5 | 95 | 3 | 29856955 | |
| Pubmed | 1.97e-07 | 5 | 95 | 3 | 18509053 | ||
| Pubmed | Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. | 1.97e-07 | 5 | 95 | 3 | 23676496 | |
| Pubmed | 3.68e-07 | 22 | 95 | 4 | 28334989 | ||
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 19110483 | ||
| Pubmed | Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. | 3.93e-07 | 6 | 95 | 3 | 21177257 | |
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 23836911 | ||
| Pubmed | 3.93e-07 | 6 | 95 | 3 | 16439465 | ||
| Pubmed | 4.27e-07 | 55 | 95 | 5 | 29997285 | ||
| Pubmed | 5.51e-07 | 175 | 95 | 7 | 28071719 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | JAG2 NR2C2 FRAS1 NELL2 MEGF8 TMEM9 SPOCK1 TK1 BTD MATN2 LAMA1 DNER LRP4 LTBP1 LTBP2 | 9.02e-07 | 1201 | 95 | 15 | 35696571 |
| Pubmed | 9.12e-07 | 118 | 95 | 6 | 21078624 | ||
| Pubmed | 9.12e-07 | 118 | 95 | 6 | 16971476 | ||
| Pubmed | 1.09e-06 | 8 | 95 | 3 | 16141228 | ||
| Pubmed | Cloning and characterization of RAP250, a novel nuclear receptor coactivator. | 1.09e-06 | 8 | 95 | 3 | 10681503 | |
| Pubmed | 1.54e-06 | 71 | 95 | 5 | 33541421 | ||
| Pubmed | 1.64e-06 | 9 | 95 | 3 | 9693030 | ||
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 1.64e-06 | 9 | 95 | 3 | 19295126 | |
| Pubmed | 1.64e-06 | 9 | 95 | 3 | 34029594 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 1.84e-06 | 133 | 95 | 6 | 15604093 | |
| Pubmed | MKRN3 TMEFF1 UBE4A ABLIM1 NELL2 MIB1 DNER LRP2 LRP4 RNF216 CADPS2 TTC3 PREPL PDLIM5 ZNF292 | 2.08e-06 | 1285 | 95 | 15 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | JAG2 ABLIM1 THRA THRB POLR1A MEGF6 LIMD1 GPR158 ANKAR NOTCH2NLA ZFHX2 PPARA CAMTA1 TECTA TTC3 PRDM15 | 2.66e-06 | 1489 | 95 | 16 | 28611215 |
| Pubmed | 3.59e-06 | 38 | 95 | 4 | 27820600 | ||
| Pubmed | 4.13e-06 | 153 | 95 | 6 | 25037231 | ||
| Pubmed | 4.90e-06 | 41 | 95 | 4 | 22675208 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16681769 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17203232 | ||
| Pubmed | Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. | 7.38e-06 | 2 | 95 | 2 | 17229846 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11861164 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24673558 | ||
| Pubmed | Expression of estrogen-related receptors in ovarian cancer and impact on survival. | 7.38e-06 | 2 | 95 | 2 | 34089362 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 22570333 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20544910 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10430610 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 37992217 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23493375 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25858550 | ||
| Pubmed | Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1. | 7.38e-06 | 2 | 95 | 2 | 15858214 | |
| Pubmed | Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice. | 7.38e-06 | 2 | 95 | 2 | 11496110 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20090848 | ||
| Pubmed | Conserved neuron promoting activity in Drosophila and vertebrate laminin alpha1. | 7.38e-06 | 2 | 95 | 2 | 8663504 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25624346 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9927422 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29544677 | ||
| Pubmed | Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. | 7.38e-06 | 2 | 95 | 2 | 17488637 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26672044 | ||
| Pubmed | Laminin 2 attachment selects myofibroblasts from fetal mouse lung. | 7.38e-06 | 2 | 95 | 2 | 9728058 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 21622534 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20062085 | ||
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 7.38e-06 | 2 | 95 | 2 | 12527922 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10346821 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17932484 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 9861043 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29771182 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34613779 | ||
| Pubmed | Repression of osteoblast maturation by ERRα accounts for bone loss induced by estrogen deficiency. | 7.38e-06 | 2 | 95 | 2 | 23359549 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19094093 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38889231 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11120878 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11867729 | ||
| Pubmed | Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. | 7.38e-06 | 2 | 95 | 2 | 19131509 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20736347 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11739587 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 10362681 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11481455 | ||
| Pubmed | Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. | 7.38e-06 | 2 | 95 | 2 | 25254665 | |
| Pubmed | Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. | 7.38e-06 | 2 | 95 | 2 | 19282388 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23300972 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26715425 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 19903799 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30143610 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 26057128 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 20141582 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 12750454 | ||
| Pubmed | Cardiac glucose utilization in mice with mutated alpha- and beta-thyroid hormone receptors. | 7.38e-06 | 2 | 95 | 2 | 15304375 | |
| Pubmed | Reduced level of epidermal growth factor in the skeletal muscle of mice with muscular dystrophy. | 7.38e-06 | 2 | 95 | 2 | 1577403 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 8652414 | ||
| Pubmed | Functionally impaired TR mutants are present in thyroid papillary cancer. | 7.38e-06 | 2 | 95 | 2 | 11889175 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38757582 | ||
| Pubmed | Distribution of the nuclear thyroid-hormone receptor in extraocular and skeletal muscles. | 7.38e-06 | 2 | 95 | 2 | 1517709 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28911178 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11222741 | ||
| Pubmed | Cloning of novel members of the steroid hormone receptor superfamily. | 7.38e-06 | 2 | 95 | 2 | 1958530 | |
| Pubmed | An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. | 7.38e-06 | 2 | 95 | 2 | 12721631 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16051666 | ||
| Pubmed | The thyroid hormone receptors as modulators of skin proliferation and inflammation. | 7.38e-06 | 2 | 95 | 2 | 21566120 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38631478 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 16781732 | ||
| Interaction | ZNF408 interactions | 2.32e-08 | 145 | 93 | 9 | int:ZNF408 | |
| Interaction | NTN5 interactions | 7.44e-08 | 24 | 93 | 5 | int:NTN5 | |
| Interaction | NCOA1 interactions | 3.79e-07 | 146 | 93 | 8 | int:NCOA1 | |
| Interaction | HOXA1 interactions | MKRN3 JAG2 CCN4 NELL2 FBLN2 OIT3 MEGF6 MEGF8 NOTCH2NLA LTBP1 ALG13 | 7.50e-07 | 356 | 93 | 11 | int:HOXA1 |
| Interaction | CACNA1A interactions | 1.63e-06 | 123 | 93 | 7 | int:CACNA1A | |
| Interaction | ATN1 interactions | 2.46e-06 | 187 | 93 | 8 | int:ATN1 | |
| Interaction | ZFP41 interactions | 6.50e-06 | 57 | 93 | 5 | int:ZFP41 | |
| Interaction | RXRB interactions | 1.34e-05 | 66 | 93 | 5 | int:RXRB | |
| Interaction | NRIP1 interactions | 1.38e-05 | 170 | 93 | 7 | int:NRIP1 | |
| Interaction | PPARGC1B interactions | 1.38e-05 | 32 | 93 | 4 | int:PPARGC1B | |
| Interaction | ZNF101 interactions | 1.57e-05 | 33 | 93 | 4 | int:ZNF101 | |
| Interaction | UBE2D4 interactions | 1.87e-05 | 119 | 93 | 6 | int:UBE2D4 | |
| Interaction | IGFL3 interactions | 2.51e-05 | 75 | 93 | 5 | int:IGFL3 | |
| Interaction | GFI1B interactions | 3.98e-05 | 136 | 93 | 6 | int:GFI1B | |
| Interaction | NCOA2 interactions | 4.88e-05 | 141 | 93 | 6 | int:NCOA2 | |
| Interaction | RXRG interactions | 6.51e-05 | 47 | 93 | 4 | int:RXRG | |
| Interaction | ZNF224 interactions | 1.02e-04 | 20 | 93 | 3 | int:ZNF224 | |
| Interaction | ZNF627 interactions | 1.02e-04 | 20 | 93 | 3 | int:ZNF627 | |
| Interaction | NUFIP2 interactions | 1.32e-04 | 417 | 93 | 9 | int:NUFIP2 | |
| Interaction | RXRA interactions | 1.33e-04 | 169 | 93 | 6 | int:RXRA | |
| Interaction | ZNF77 interactions | 1.37e-04 | 22 | 93 | 3 | int:ZNF77 | |
| Interaction | ATXN7 interactions | 1.50e-04 | 109 | 93 | 5 | int:ATXN7 | |
| Interaction | LAMA2 interactions | 1.58e-04 | 23 | 93 | 3 | int:LAMA2 | |
| Interaction | LPXN interactions | 1.93e-04 | 115 | 93 | 5 | int:LPXN | |
| Interaction | FGD4 interactions | 2.18e-04 | 64 | 93 | 4 | int:FGD4 | |
| Interaction | PDLIM7 interactions | 2.22e-04 | 264 | 93 | 7 | int:PDLIM7 | |
| Interaction | FBN2 interactions | 2.32e-04 | 65 | 93 | 4 | int:FBN2 | |
| Interaction | ARHGAP26 interactions | 2.36e-04 | 120 | 93 | 5 | int:ARHGAP26 | |
| Cytoband | 12q12 | 2.87e-06 | 47 | 95 | 4 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 9.33e-06 | 63 | 95 | 4 | chr12q12 | |
| Cytoband | 7q31.3 | 4.37e-04 | 15 | 95 | 2 | 7q31.3 | |
| Cytoband | 3p25 | 5.65e-04 | 17 | 95 | 2 | 3p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 2.77e-03 | 134 | 95 | 3 | chr7p22 | |
| Cytoband | 4q13.3 | 3.46e-03 | 42 | 95 | 2 | 4q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p25 | 4.16e-03 | 155 | 95 | 3 | chr3p25 | |
| Cytoband | 7p22.1 | 4.31e-03 | 47 | 95 | 2 | 7p22.1 | |
| GeneFamily | Nuclear hormone receptors | 5.53e-12 | 49 | 63 | 8 | 71 | |
| GeneFamily | LIM domain containing | 1.31e-09 | 59 | 63 | 7 | 1218 | |
| GeneFamily | Prickle planar cell polarity proteins|LIM domain containing | 1.61e-07 | 4 | 63 | 3 | 1184 | |
| GeneFamily | CD molecules|Mucins | 5.13e-05 | 21 | 63 | 3 | 648 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 7.14e-05 | 4 | 63 | 2 | 628 | |
| GeneFamily | Laminin subunits | 7.71e-04 | 12 | 63 | 2 | 626 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.10e-04 | 718 | 63 | 9 | 28 | |
| GeneFamily | Low density lipoprotein receptors | 9.09e-04 | 13 | 63 | 2 | 634 | |
| GeneFamily | Ring finger proteins | 2.69e-03 | 275 | 63 | 5 | 58 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 3.40e-03 | 25 | 63 | 2 | 74 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN4 FRAS1 NELL2 NTNG2 SRPX2 FBLN2 OIT3 OTOGL MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA | 2.79e-16 | 191 | 94 | 15 | MM17059 |
| Coexpression | NABA_MATRISOME | HYAL4 CCN4 FAM20C FRAS1 NELL2 EREG NTNG2 SRPX2 FBLN2 OIT3 EGF MEGF6 MEGF8 ADAMTS3 SPOCK1 OTOGL MATN2 MATN3 LAMA1 MUC19 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC | 1.06e-15 | 1008 | 94 | 26 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | CCN4 FRAS1 NELL2 NTNG2 SRPX2 FBLN2 OIT3 SPOCK1 OTOGL MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA | 2.30e-15 | 270 | 94 | 16 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | CCN4 FRAS1 NELL2 NTNG2 SRPX2 FBLN2 OIT3 MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA | 1.10e-14 | 196 | 94 | 14 | M3008 |
| Coexpression | NABA_MATRISOME | HYAL4 CCN4 FAM20C FRAS1 NELL2 EREG NTNG2 SRPX2 FBLN2 OIT3 EGF MEGF6 MEGF8 ADAMTS3 SPOCK1 MATN2 MATN3 LAMA1 MUC19 LAMA2 LTBP1 LTBP2 TECTA MUC2 MUC5AC | 1.53e-14 | 1026 | 94 | 25 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | CCN4 FRAS1 NELL2 NTNG2 SRPX2 FBLN2 OIT3 SPOCK1 MATN2 MATN3 LAMA1 LAMA2 LTBP1 LTBP2 TECTA | 6.21e-14 | 275 | 94 | 15 | M5884 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | JAG2 THRA MEGF6 ADAMTS3 SPOCK1 GPR158 ANKAR ESRRG CNTNAP2 DNER PRICKLE2 MUC19 ZFHX2 CAMTA1 SPAG17 TTC3 MUC2 PREPL | 6.78e-08 | 1106 | 94 | 18 | M39071 |
| Coexpression | MIKI_COEXPRESSED_WITH_CYP19A1 | 1.55e-06 | 7 | 94 | 3 | M1868 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | JAG2 SEC24D NELL2 EREG MEGF6 SPOCK1 MKRN1 NOTCH2NLA PPARA RALGAPA2 TTC3 ZNF292 | 3.54e-06 | 648 | 94 | 12 | M14371 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 2.25e-05 | 235 | 94 | 7 | M2256 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.54e-05 | 200 | 94 | 6 | M5930 | |
| Coexpression | GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN | 8.54e-05 | 200 | 94 | 6 | M8465 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.06e-04 | 208 | 94 | 6 | M39233 | |
| Coexpression | DANG_REGULATED_BY_MYC_UP | 1.06e-04 | 68 | 94 | 4 | M18501 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-10 | 180 | 95 | 9 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-10 | 189 | 95 | 9 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-10 | 190 | 95 | 9 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-10 | 192 | 95 | 9 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-10 | 194 | 95 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-09 | 160 | 95 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-09 | 160 | 95 | 8 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-09 | 160 | 95 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-09 | 184 | 95 | 8 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.84e-09 | 187 | 95 | 8 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.84e-09 | 187 | 95 | 8 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.84e-09 | 187 | 95 | 8 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-09 | 188 | 95 | 8 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-09 | 190 | 95 | 8 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-09 | 191 | 95 | 8 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-09 | 191 | 95 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-09 | 191 | 95 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-08 | 175 | 95 | 7 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 178 | 95 | 7 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 180 | 95 | 7 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-07 | 180 | 95 | 7 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-07 | 185 | 95 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-07 | 185 | 95 | 7 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-07 | 187 | 95 | 7 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.61e-07 | 188 | 95 | 7 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-07 | 188 | 95 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-07 | 188 | 95 | 7 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-07 | 189 | 95 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-07 | 189 | 95 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-07 | 191 | 95 | 7 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-07 | 191 | 95 | 7 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-07 | 191 | 95 | 7 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 195 | 95 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 195 | 95 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 195 | 95 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 195 | 95 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-07 | 196 | 95 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-07 | 196 | 95 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-07 | 196 | 95 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-07 | 198 | 95 | 7 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-07 | 200 | 95 | 7 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.45e-07 | 200 | 95 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.45e-07 | 200 | 95 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.45e-07 | 200 | 95 | 7 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.45e-07 | 200 | 95 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.45e-07 | 200 | 95 | 7 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.19e-06 | 159 | 95 | 6 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-06 | 170 | 95 | 6 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 175 | 95 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-06 | 176 | 95 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 178 | 95 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-06 | 178 | 95 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 178 | 95 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 179 | 95 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 183 | 95 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-06 | 183 | 95 | 6 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.77e-06 | 184 | 95 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.80e-06 | 103 | 95 | 5 | 39d8cfb899ca88c72ebe021d66cc21ae2eb6a1cc | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.80e-06 | 103 | 95 | 5 | 01a7baaa0c3903bd00e37717856d2c1ac21bf2c8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-06 | 185 | 95 | 6 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.86e-06 | 185 | 95 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-06 | 185 | 95 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 186 | 95 | 6 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 186 | 95 | 6 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.04e-06 | 187 | 95 | 6 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.14e-06 | 188 | 95 | 6 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 188 | 95 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-06 | 188 | 95 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.14e-06 | 188 | 95 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 189 | 95 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 189 | 95 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 189 | 95 | 6 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 190 | 95 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-06 | 190 | 95 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.38e-06 | 107 | 95 | 5 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.38e-06 | 107 | 95 | 5 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-06 | 191 | 95 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.54e-06 | 192 | 95 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-06 | 192 | 95 | 6 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-06 | 192 | 95 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-06 | 192 | 95 | 6 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 193 | 95 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 193 | 95 | 6 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 193 | 95 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.65e-06 | 193 | 95 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 193 | 95 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.76e-06 | 194 | 95 | 6 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 95 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 95 | 6 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 95 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.76e-06 | 194 | 95 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-06 | 194 | 95 | 6 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.76e-06 | 194 | 95 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.76e-06 | 194 | 95 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 195 | 95 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-06 | 195 | 95 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.87e-06 | 195 | 95 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 195 | 95 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| Drug | AC1L9K70 | 4.40e-07 | 228 | 94 | 9 | CID000446871 | |
| Drug | MCDF | 5.17e-06 | 28 | 94 | 4 | CID000114900 | |
| Drug | U23,469 | 5.62e-06 | 9 | 94 | 3 | CID000161922 | |
| Drug | E-guggulsterone | 5.75e-06 | 108 | 94 | 6 | CID006439929 | |
| Drug | CDRI-85/287 | 5.98e-06 | 29 | 94 | 4 | CID000159508 | |
| Drug | LY117018 | 5.98e-06 | 29 | 94 | 4 | CID000104946 | |
| Drug | zirconium | 6.73e-06 | 111 | 94 | 6 | CID000023995 | |
| Drug | 3-trifluoromethyl-4-nitrophenol | 8.50e-06 | 67 | 94 | 5 | CID000006931 | |
| Drug | 1wvj | 9.83e-06 | 69 | 94 | 5 | CID005288598 | |
| Drug | UVI 3003 | 1.10e-05 | 11 | 94 | 3 | ctd:C525131 | |
| Drug | hydroxyethylretinamide | 1.30e-05 | 73 | 94 | 5 | CID006437840 | |
| Drug | AC1O0B8G | 1.31e-05 | 262 | 94 | 8 | CID000091605 | |
| Drug | muraglitazar | 1.51e-05 | 444 | 94 | 10 | ctd:C500085 | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A | 1.60e-05 | 194 | 94 | 7 | 5836_UP | |
| Drug | Levothyroxine | 1.69e-05 | 2 | 94 | 2 | DB00451 | |
| Drug | Liothyronine | 1.69e-05 | 2 | 94 | 2 | DB00279 | |
| Drug | Liotrix | 1.69e-05 | 2 | 94 | 2 | DB01583 | |
| Drug | N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide | 1.69e-05 | 2 | 94 | 2 | ctd:C501618 | |
| Drug | 3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid | 1.69e-05 | 2 | 94 | 2 | DB03176 | |
| Drug | KB 130015 | 1.69e-05 | 2 | 94 | 2 | ctd:C446946 | |
| Drug | Rafoxanide | 1.69e-05 | 2 | 94 | 2 | ctd:D011888 | |
| Drug | E)-4-hydroxytamoxifen | 1.77e-05 | 197 | 94 | 7 | CID000063062 | |
| Drug | 1pxm | 1.79e-05 | 78 | 94 | 5 | CID000447959 | |
| Drug | ketononestrol aziridine | 1.89e-05 | 13 | 94 | 3 | CID000130642 | |
| Drug | 2-phenylindole | 1.89e-05 | 13 | 94 | 3 | CID000013698 | |
| Drug | isocycloheximide | EREG THRA POLR1A EGF TK1 ESRRA ESRRB ESRRG LAMA1 MIB1 LRP2 LAMA2 LRP4 PDLIM5 | 2.01e-05 | 905 | 94 | 14 | CID000002900 |
| Drug | 2,2',4,4'-tetrahydroxybenzophenone | 2.40e-05 | 14 | 94 | 3 | ctd:C035476 | |
| Drug | Goserelin | 2.45e-05 | 41 | 94 | 4 | CID000047725 | |
| Drug | n-octylphenol | 2.97e-05 | 43 | 94 | 4 | CID000013700 | |
| Drug | AC1Q7B2S | 2.99e-05 | 15 | 94 | 3 | CID000015019 | |
| Drug | benzophenone-2 | 2.99e-05 | 15 | 94 | 3 | CID000008571 | |
| Drug | 1q4x | 3.67e-05 | 16 | 94 | 3 | CID000448011 | |
| Drug | TAT-59 | 3.67e-05 | 16 | 94 | 3 | CID003034829 | |
| Drug | OH-PCB 30 | 3.67e-05 | 16 | 94 | 3 | CID000105036 | |
| Drug | bisphenol A | 3.91e-05 | 223 | 94 | 7 | CID000006623 | |
| Drug | AC1L2E0P | 4.07e-05 | 307 | 94 | 8 | CID000019390 | |
| Drug | Implanon | 4.24e-05 | 47 | 94 | 4 | CID000040976 | |
| Drug | tesaglitazar | 4.28e-05 | 502 | 94 | 10 | ctd:C501413 | |
| Drug | tetrachlorobisphenol A | 4.44e-05 | 17 | 94 | 3 | CID000006619 | |
| Drug | AC1L1GHE | 4.90e-05 | 96 | 94 | 5 | CID000003684 | |
| Drug | ethylnylestradiol | NR2C2 EREG THRA THRB EGF CSK TK1 ESRRA ESRRB ESRRG MIB1 LRP2 LRP4 PPARA PDLIM5 NR1H4 | 4.98e-05 | 1251 | 94 | 16 | CID000003285 |
| Drug | Dextrothyroxine | 5.05e-05 | 3 | 94 | 2 | DB00509 | |
| Drug | ankaflavin | 5.05e-05 | 3 | 94 | 2 | ctd:C499916 | |
| Drug | Bithionol | 5.05e-05 | 3 | 94 | 2 | ctd:D001735 | |
| Drug | p,p'-hydroxy-DDT | 5.43e-05 | 50 | 94 | 4 | CID000076302 | |
| Drug | ORG 2058 | 5.87e-05 | 51 | 94 | 4 | CID000119086 | |
| Drug | 8-prenylnaringenin | 6.34e-05 | 52 | 94 | 4 | CID000480764 | |
| Drug | 2-oyl | 7.51e-05 | 105 | 94 | 5 | CID000657137 | |
| Drug | Vanadates | FAM20C ABLIM1 EREG SRPX2 THRB EGF PRICKLE1 SPOCK1 LAMA1 DNER PRICKLE2 ZNF429 LTBP1 LTBP2 PDLIM5 ZNF239 | 7.99e-05 | 1302 | 94 | 16 | ctd:D014638 |
| Drug | AC1L2JTN | 8.59e-05 | 21 | 94 | 3 | CID000022150 | |
| Drug | indenestrol A | 8.59e-05 | 21 | 94 | 3 | CID000107664 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | JAG2 FAM20C NELL2 THRB EGF ESRRA ESRRB ESRRG LAMA1 MIB1 DNER PRICKLE2 LAMA2 | 9.09e-05 | 909 | 94 | 13 | CID000002524 |
| Drug | sodium molybdate | 9.10e-05 | 57 | 94 | 4 | CID000061424 | |
| Drug | indenestrol B | 9.91e-05 | 22 | 94 | 3 | CID000114716 | |
| Drug | tamoxifen aziridine | 9.91e-05 | 22 | 94 | 3 | CID003033894 | |
| Drug | KB-141 | 1.01e-04 | 4 | 94 | 2 | CID009863447 | |
| Drug | phosphonoacetaldehyde | 1.02e-04 | 112 | 94 | 5 | CID000000490 | |
| Drug | AC1L3UEY | 1.06e-04 | 113 | 94 | 5 | CID000122342 | |
| Drug | dihydroacarbose | 1.06e-04 | 113 | 94 | 5 | CID000174450 | |
| Drug | AC1ND2OB | 1.16e-04 | 265 | 94 | 7 | CID004568637 | |
| Drug | phenol red | 1.19e-04 | 61 | 94 | 4 | CID000004766 | |
| Drug | Equilin sodium sulfate | 1.43e-04 | 64 | 94 | 4 | CID000027993 | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; HL60; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 1264_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 6727_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A | 1.59e-04 | 195 | 94 | 6 | 1884_UP | |
| Drug | SQ 27,860 | 1.67e-04 | 5 | 94 | 2 | CID000134085 | |
| Drug | 2,3',5,5'-tetrachlorobiphenyl | 1.67e-04 | 5 | 94 | 2 | CID000038878 | |
| Drug | 4-hydroxy-2,2',5,5'-tetrachlorobiphenyl | 1.67e-04 | 5 | 94 | 2 | CID000039971 | |
| Drug | diHPA | 1.67e-04 | 5 | 94 | 2 | CID000151819 | |
| Drug | 4-(3-chloroanilino)quinazoline | 1.67e-04 | 5 | 94 | 2 | CID000128872 | |
| Drug | XCT790 | 1.67e-04 | 5 | 94 | 2 | CID006918788 | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5785_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4432_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 6248_UP | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 4428_UP | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 3140_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.78e-04 | 199 | 94 | 6 | 1055_DN | |
| Drug | 2C5P | 1.84e-04 | 127 | 94 | 5 | CID000447961 | |
| Drug | DAPH1 | 1.86e-04 | 27 | 94 | 3 | CID000133027 | |
| Drug | idoxifene | 1.86e-04 | 27 | 94 | 3 | CID003034011 | |
| Drug | nafoxidine | 1.86e-04 | 27 | 94 | 3 | CID000004416 | |
| Drug | coumestrol | 1.92e-04 | 69 | 94 | 4 | CID005281707 | |
| Drug | RU 16117 | 2.07e-04 | 28 | 94 | 3 | CID000066408 | |
| Drug | dihydroequilenin | 2.07e-04 | 28 | 94 | 3 | CID000003247 | |
| Drug | methoxychlor | 2.26e-04 | 72 | 94 | 4 | CID000004115 | |
| Drug | cuprizone | 2.26e-04 | 72 | 94 | 4 | CID000009723 | |
| Drug | hexestrol | 2.30e-04 | 29 | 94 | 3 | CID000003606 | |
| Drug | Tl-I | 2.30e-04 | 29 | 94 | 3 | CID006432721 | |
| Drug | alpha-zearalanol | 2.30e-04 | 29 | 94 | 3 | CID000022283 | |
| Drug | homoserine | 2.38e-04 | 73 | 94 | 4 | CID000000779 | |
| Drug | naamidine A | 2.50e-04 | 6 | 94 | 2 | CID000188306 | |
| Drug | AR14 | 2.50e-04 | 6 | 94 | 2 | CID000046038 | |
| Drug | CV-1 | 2.57e-04 | 213 | 94 | 6 | CID000130105 | |
| Drug | AC1L1HMM | 2.84e-04 | 516 | 94 | 9 | CID000004196 | |
| Drug | butyl benzyl phthalate | 3.10e-04 | 32 | 94 | 3 | CID000002347 | |
| Drug | o,p'-DDE | 3.10e-04 | 32 | 94 | 3 | CID000246598 | |
| Drug | Emetine | 3.10e-04 | 32 | 94 | 3 | ctd:D004640 | |
| Drug | schizandrin | 3.10e-04 | 32 | 94 | 3 | CID000023915 | |
| Drug | NSC35770 | 3.39e-04 | 80 | 94 | 4 | CID000002800 | |
| Drug | RU 58668 | 3.40e-04 | 33 | 94 | 3 | CID000119604 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.94e-07 | 80 | 92 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | cystitis (is_marker_for) | 9.62e-06 | 2 | 92 | 2 | DOID:1679 (is_marker_for) | |
| Disease | thyroid hormone resistance syndrome (implicated_via_orthology) | 2.88e-05 | 3 | 92 | 2 | DOID:11633 (implicated_via_orthology) | |
| Disease | sputum mucin-5B amount | 2.88e-05 | 3 | 92 | 2 | OBA_2050332 | |
| Disease | orofaciodigital syndrome (is_implicated_in) | 2.88e-05 | 3 | 92 | 2 | DOID:4501 (is_implicated_in) | |
| Disease | Generalized Thyroid Hormone Resistance | 5.75e-05 | 4 | 92 | 2 | C4722330 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.98e-05 | 447 | 92 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | azoospermia (implicated_via_orthology) | 8.13e-05 | 27 | 92 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 9.56e-05 | 5 | 92 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.56e-05 | 5 | 92 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | JAG2 EREG LIPE EGF PRICKLE3 OTOGL ESRRA LAMA2 TECTA DLL1 TTC3 ZNF646 | 1.26e-04 | 1074 | 92 | 12 | C0006142 |
| Disease | testosterone measurement | ZC3H7A UBE4A NTNG2 LIPE THRB POLR1A TMEM9 ADAMTS3 ESRRG CNTNAP2 PPARA NR1H4 KIAA0753 | 1.61e-04 | 1275 | 92 | 13 | EFO_0004908 |
| Disease | Autistic Disorder | 1.71e-04 | 261 | 92 | 6 | C0004352 | |
| Disease | Polysyndactyly | 2.00e-04 | 7 | 92 | 2 | C0265553 | |
| Disease | Syndactyly | 2.66e-04 | 8 | 92 | 2 | C0039075 | |
| Disease | Diaphragmatic Hernia | 2.87e-04 | 41 | 92 | 3 | C0019284 | |
| Disease | oral microbiome measurement | 3.08e-04 | 42 | 92 | 3 | EFO_0801229 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 3.41e-04 | 9 | 92 | 2 | EFO_0009824 | |
| Disease | Schizophrenia | JAG2 NTNG2 ADAMTS3 LAMA1 CNTNAP2 LRP2 LAMA2 PPARA CADPS2 PDLIM5 | 4.31e-04 | 883 | 92 | 10 | C0036341 |
| Disease | Intellectual Disability | 5.06e-04 | 447 | 92 | 7 | C3714756 | |
| Disease | Crohn Disease | 5.17e-04 | 50 | 92 | 3 | C0010346 | |
| Disease | Intestinal Neoplasms | 6.22e-04 | 12 | 92 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 6.22e-04 | 12 | 92 | 2 | C0346627 | |
| Disease | triacylglycerol 58:12 measurement | 6.22e-04 | 12 | 92 | 2 | EFO_0010439 | |
| Disease | body mass index, osteoarthritis | 6.48e-04 | 54 | 92 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | body surface area | 9.09e-04 | 643 | 92 | 8 | EFO_0022196 | |
| Disease | cystic fibrosis (is_marker_for) | 9.71e-04 | 62 | 92 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.12e-03 | 16 | 92 | 2 | C0751885 | |
| Disease | Abnormal behavior | 1.12e-03 | 16 | 92 | 2 | C0233514 | |
| Disease | radiation-induced disorder | 1.22e-03 | 67 | 92 | 3 | EFO_0009565 | |
| Disease | serum IgG glycosylation measurement | 1.26e-03 | 523 | 92 | 7 | EFO_0005193 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.27e-03 | 17 | 92 | 2 | C0751883 | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.38e-03 | 70 | 92 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.38e-03 | 70 | 92 | 3 | C3241937 | |
| Disease | level of Sphingomyelin (d34:1) in blood serum | 1.42e-03 | 18 | 92 | 2 | OBA_2045175 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 1.42e-03 | 18 | 92 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.59e-03 | 19 | 92 | 2 | C0751884 | |
| Disease | epilepsy (implicated_via_orthology) | 1.72e-03 | 163 | 92 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | energy expenditure measurement | 1.76e-03 | 20 | 92 | 2 | EFO_0008005 | |
| Disease | Nonsyndromic Deafness | 2.10e-03 | 81 | 92 | 3 | C3711374 | |
| Disease | remission, hepatitis C virus infection | 2.33e-03 | 23 | 92 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.51e-03 | 181 | 92 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Myasthenic Syndromes, Congenital | 2.54e-03 | 24 | 92 | 2 | C0751882 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.54e-03 | 24 | 92 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Kidney Diseases | 2.66e-03 | 88 | 92 | 3 | C0022658 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.75e-03 | 25 | 92 | 2 | DOID:12236 (is_marker_for) | |
| Disease | susceptibility to plantar warts measurement | 2.83e-03 | 90 | 92 | 3 | EFO_0008406 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVQGVECLYGCYVHS | 141 | Q9Y6Y1 | |
| GDKCQVCLESEGRYY | 496 | Q9NP73 | |
| CTLDYQRMYGTRCHG | 146 | O14639 | |
| YTLCVSCDGKVEHYR | 116 | P41240 | |
| AICDPHRGLYCDYSG | 91 | O95388 | |
| YGICKEGDNCRYSHD | 101 | Q13434 | |
| YCVVCGDKASGRHYG | 116 | P49116 | |
| YCKCPEGFLGEYCQH | 11 | Q7Z3S9 | |
| LCVVCGDRASGYHYN | 136 | Q96RI1 | |
| CYHLYSGIEEVRAAC | 1261 | Q7Z5J8 | |
| ACTYGHEDCVKALVY | 536 | Q96NW4 | |
| GYYADATGRCKVCHN | 596 | Q86XX4 | |
| DYCLLSDHGCEYSCV | 486 | O00339 | |
| CVNDRSGSYHCECYE | 321 | O15232 | |
| RDYHVECYHCEDCGL | 621 | Q9UGP4 | |
| AYCEDIDECAEGRHY | 436 | Q99435 | |
| VLGAYECICKAGFYH | 346 | Q5T848 | |
| GCGHDECDTYVRVCL | 61 | Q9Y219 | |
| RSCEKIGDSYRGYCV | 211 | Q8N187 | |
| YCRQGYQLAEDGHTC | 966 | P98095 | |
| EGYTCDCFDGYHLDT | 1641 | Q14766 | |
| HVYCGHFYDICDEDC | 141 | Q8WWZ8 | |
| GLCQYSFLEDYCGHE | 1296 | Q7Z5P9 | |
| AKCSCYHRGLYLEAG | 716 | Q02817 | |
| TLAAGYYHTECVSGC | 786 | Q02817 | |
| LSYECHCQRGYQGDG | 1096 | Q7Z7M0 | |
| CHGKAEECYYDENVA | 346 | P24043 | |
| DFCERCALGYYGIVK | 1446 | P24043 | |
| CHCEEGYILERGQYC | 371 | P98164 | |
| RDLAGHCYYALCSQD | 4801 | P98088 | |
| CETDYYALFGTICHG | 526 | Q96HC4 | |
| DYIYRVLHCCVCGSS | 1296 | Q2PPJ7 | |
| GGADKYHSVCRLCYF | 176 | P04183 | |
| YCKCPEGFLGEYCQH | 11 | P0DPK4 | |
| GAYRCCGCFSHSRYE | 191 | Q9H7L2 | |
| AECTNYDLCTVCYHG | 101 | Q86YT6 | |
| LYAEYCETCGEHIGV | 246 | Q96MT3 | |
| YQDGKIYCGRHHAEC | 176 | Q7Z3G6 | |
| YAEYCDTCAQHIGID | 251 | Q7Z3G6 | |
| ACYEARHAEYCDGCG | 301 | O43900 | |
| GYRECHNGKCYRLEQ | 1486 | Q5VYJ5 | |
| CSGQELKRYIHSYDC | 441 | O15072 | |
| LKSGYGEHVCYVLDC | 136 | Q9NWB7 | |
| HDGCKGRYVEDICVY | 351 | Q6ZNI0 | |
| DGYCLHDGVCMYIEA | 981 | P01133 | |
| RFVCDEHYYGEGCSV | 176 | O00548 | |
| GRYCDECIRYPGCLH | 251 | O00548 | |
| ECSYYCSTEHALCGK | 366 | Q8IXL6 | |
| RLCLVCGDIASGYHY | 126 | P62508 | |
| SGYHYGVASCEACKA | 136 | P62508 | |
| HCYQGYEGADCREIK | 436 | Q2M3T9 | |
| KEGYLHVCSNGLCCY | 411 | P43251 | |
| VLDEYCARYGVRGCH | 676 | Q86UW7 | |
| VLCVHGYCENTEGSY | 1786 | Q14767 | |
| GYCENTEGSYRCHCS | 1791 | Q14767 | |
| NGGKCLERYHGYSCD | 976 | Q9UHC6 | |
| YCRCEVGYTGVRCEH | 91 | O14944 | |
| RLCLVCGDIASGYHY | 101 | O95718 | |
| SGYHYGVASCEACKA | 111 | O95718 | |
| AHESEIYCKVCYGRR | 51 | P50461 | |
| CLCDPGYHGLYCEEE | 491 | Q8NFT8 | |
| GYECVCLAEYKGTHC | 526 | Q8NFT8 | |
| ASGYHYGVASCEACK | 86 | P11474 | |
| EYVTLHKGCFYGRCL | 456 | Q05469 | |
| GLYYQLCRHDACKCG | 696 | Q3ZCN5 | |
| AAYAYKCCQEGISIH | 1181 | Q3ZCN5 | |
| ECRICGDKASGYHYG | 101 | Q07869 | |
| GYCIYGDRCRYEHSK | 96 | Q9UHC7 | |
| ECRYGENCVYLHGDS | 221 | Q9UHC7 | |
| RYYYDCIRVHCKGDD | 131 | Q4G0U5 | |
| CHAGYELGADGRQCY | 311 | O75095 | |
| GNCECYGHSNRCSYI | 351 | Q96CW9 | |
| LVHCCYEIYGGETSG | 761 | O95602 | |
| NEVDGEYRYRCGTCE | 791 | P57071 | |
| EGYTGEKCDRCQLGY | 431 | P25391 | |
| DRCAHGFYAYQDGSC | 981 | P25391 | |
| LGYEGKHCERCSSSY | 1481 | P25391 | |
| SGVEEDHECVYCYRV | 231 | Q5JXC2 | |
| YQKDGQLIECRCCYG | 506 | Q9NWF9 | |
| YNESYHCKDADCRVG | 66 | Q2KHM9 | |
| YGGSSYVDFLCCVHK | 1011 | O94855 | |
| GSLYIDKDCSAVYCH | 1536 | Q6Q759 | |
| YCVEGCHCDAGYVLN | 1401 | O75443 | |
| GHDVEAYCLLCECRY | 66 | Q9P0T7 | |
| CDVKYDFYVSCRGHL | 2151 | Q9C0A1 | |
| CRYYIHGQCKEGENC | 101 | Q13064 | |
| ATCEYHCDGGYDRQG | 286 | O60687 | |
| FECRCGNVYCGVHRY | 161 | Q6FIF0 | |
| CYECGEKGHYAYDCH | 106 | Q16629 | |
| CERYNHGTVVEFYCD | 261 | Q5VX71 | |
| LCVVCGDKATGYHYR | 106 | P10828 | |
| GDKATGYHYRCITCE | 111 | P10828 | |
| GYHYRCITCEGCKGF | 116 | P10828 | |
| YKCDCEGCDRIYATR | 2256 | O60281 | |
| YGHICGCCGQTYDDL | 956 | O15015 | |
| RCNEEGYYKATQCHG | 336 | Q08629 | |
| VPDAICCYQKCHGYS | 646 | P53804 | |
| KHGGFVYYQEGCCLV | 116 | Q4J6C6 | |
| AEEECRYSGHCTFAY | 511 | Q8IWR0 | |
| KCYECGESGHLSYAC | 106 | Q8TBF4 | |
| RIYVGEKHYRCEECG | 221 | Q86V71 | |
| EQCVVCGDKATGYHY | 51 | P10827 | |
| CGDKATGYHYRCITC | 56 | P10827 | |
| TGYHYRCITCEGCKG | 61 | P10827 | |
| QRTHTGEKAYECYEC | 596 | P17014 | |
| RDAGERHIFCYLYSC | 166 | Q14139 | |
| GYCIHGKCEFIYSTQ | 281 | Q8IYR6 | |
| RCIHTGEKPYQCYEC | 366 | Q16600 | |
| IHTGEYPYECHDCGR | 306 | Q8N988 | |
| AYECNRCGKAYRHDS | 466 | Q49AA0 | |
| FQCAYGRCILDIYHC | 196 | O75096 |